Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Brands

Mamedica

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
23
Portfolio
19 Strains
Mentions (90d)
68
Brand Score (90d)
67
vs Market Avg: 64 vs All Time: 64
Performing Well

Rating higher than the 90d community baseline.

Medication Portfolio (19)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
14
23.6%
4
56
65
26
25.0% Yes
1
70
60
28
Cap Junky
30.0% Yes
17
63
66
133
25.0% Yes
3
69
64
161
26.0%
0
-
54
165
20.0%
0
-
56
188
25.0%
20
62
62
204
25.0%
22
68
68
227
27.0%
0
-
57
288
24.0%
11
66
66
296
27.0%
10
72
72
303
28.0%
0
-
74
349
28.0%
1
91
69
353
28.0%
0
-
57
368
25.0%
1
91
79
374
28.0%
0
-
60
381
26.8%
3
81
85
401
26.0%
0
-
76
461
0
-
N/A